Nicotinic receptors have emerged as potential targets for reversing cognitive deficits in AD (68), owing to their noted potent regulation by Aβ, but there remains a need to determine the roles of specific nAChR subtypes in AD. Here, CHRNA4 is linked to Alzheimer disease.